BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6929935)

  • 1. Neutrophil surface markers in chronic myelocytic leukemia.
    Yokoyama MM; Nishiki M; Matsui Y; Crispen R; Jerdan M
    Kurume Med J; 1980; 27(1):43-9. PubMed ID: 6929935
    [No Abstract]   [Full Text] [Related]  

  • 2. Assignment of the leucocyte group five surface antigens to human chromosome 4.
    Geurts van Kessel AH; Stoker K; Claas FH; van Agthoven AJ; Hagemeijer A
    Tissue Antigens; 1983 Mar; 21(3):213-8. PubMed ID: 6574615
    [No Abstract]   [Full Text] [Related]  

  • 3. A marker of neutrophil heterogeneity reveals two forms of chronic myelogenous leukemia.
    Gallin JI; Jacobson RJ; Seligmann B; Metcalf JA; McKay J; Sacher RA; Malech HL
    Trans Assoc Am Physicians; 1985; 98():166-70. PubMed ID: 3870297
    [No Abstract]   [Full Text] [Related]  

  • 4. [Detection of B-cell antigen on the blast cells in chronic myeloid leukemia].
    Morozova LF; Belianchikova NI; Radzikhovskaia RM; Baryshnikov AIu; Volkova MA
    Biull Eksp Biol Med; 1979 Jun; 87(6):574-6. PubMed ID: 380683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic phenotype of leukemia cells in children with myelocytic leukemia].
    Tupitsyn NP; Drozdova TS; Baryshnikov AIu; Makhonova LA
    Pediatriia; 1986 Aug; (8):25-7. PubMed ID: 2945159
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
    Van 't Veer MB; Tetteroo PA; Von dem Borne KR; Engelfriet CP
    Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigens differentially expressed on surface and cytoplasmic structures of human myeloid cells.
    Fitz-Gibbon L; Shematek G; Sullivan AK
    Leuk Res; 1985; 9(1):123-34. PubMed ID: 3857403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile chronic myelogenous leukemia: surface antigen phenotyping by monoclonal antibodies and cytogenetic studies.
    Shannon K; Nunez G; Dow LW; Weinberg AG; Sato Y; Stastny P; Buchanan GR
    Pediatrics; 1986 Mar; 77(3):330-5. PubMed ID: 3513115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purificaton and characterization of a new antigen from human polymorphonuclears.
    Rojas Moreno M; Goulu C; Fondaneche MC; Bourillon R; Burtin P
    Immunol Lett; 1985; 9(4):215-20. PubMed ID: 3888833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients.
    Wahren B; Gahrton G; Hammarström S
    Cancer Res; 1980 Jun; 40(6):2039-44. PubMed ID: 6929221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic neutrophilic leukemia showing surface markers of MY7+, MY9-, OKB2+ and OKMI+--a case report].
    Kato S; Sato M; Nakamura K
    Nihon Naika Gakkai Zasshi; 1986 Jun; 75(6):792-8. PubMed ID: 3462280
    [No Abstract]   [Full Text] [Related]  

  • 14. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
    J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute leukemia evolving from multiple myeloma and co-expressing myeloid and plasma cell antigens.
    Stewart AK; Freedman J; Garvey MB
    Am J Hematol; 1990 Jul; 34(3):210-4. PubMed ID: 2363415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Childhood chronic myelogenous leukemia with blastic crisis showing pre-B cell and myelocytic phenotypes].
    Nakadate H; Kobayashi R; Yanazume M; Nishi M; Hattori T; Hatae Y; Takeda T
    Rinsho Ketsueki; 1987 Jan; 28(1):76-80. PubMed ID: 3494864
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relation between the phagocytic function and expression of surface receptors of granulocytes in myelocytic leukemia].
    Tishchenko LM; Guseva SA
    Gematol Transfuziol; 1986 Jul; 31(7):28-32. PubMed ID: 3462083
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukemic myeloblasts expressing lymphoid markers.
    Reizenstein P; Beksac M; Biberfeld P; Christensson B; Lagerlöf B; Laurén L; Ost A; Porwit A
    Acta Haematol; 1985; 74(3):148-50. PubMed ID: 2937254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early T-cell features in blast crisis of Ph1-positive chronic myeloid leukaemia.
    Cervantes F; Anegon I; Rozman C; Gallart T; Pereira A; Vives-Corrons JL; Casademont J; Urbano-Marquez A
    Scand J Haematol; 1985 Jul; 35(1):71-6. PubMed ID: 3931208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous occurrence of chronic granulocytic leukemia and chronic lymphoid leukemia.
    Leoni F; Ferrini PR; Castoldi GL; Pata M; Del Prete GF; Tomasi P
    Haematologica; 1987; 72(3):253-6. PubMed ID: 3114094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.